-
1
-
-
79952945610
-
-
Web site Accessed June, 2011
-
SEER Stat Fact Sheets: breast. Surveillance, Epidemiology and End Results Web site. http://seer.cancer.gov/statfacts/html/breast.html. Accessed June, 2011.
-
SEER Stat Fact Sheets: Breast
-
-
-
2
-
-
7044249435
-
Web-based survey of fertility issues in young women with breast cancer
-
DOI 10.1200/JCO.2004.01.159
-
Partridge AH, Gelber S, Peppercorn J, et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol. 2004;22(20):4174-4183. (Pubitemid 41185188)
-
(2004)
Journal of Clinical Oncology
, vol.22
, Issue.20
, pp. 4174-4183
-
-
Partridge, A.H.1
Gelber, S.2
Peppercorn, J.3
Sampson, E.4
Knudsen, K.5
Laufer, M.6
Rosenberg, R.7
Przypyszny, M.8
Rein, A.9
Winer, E.P.10
-
3
-
-
0015867606
-
Cyclophosphamide-induced ovarian failure
-
Warne GL, Fairley KF, Hobbs JB, Martin FI. Cyclophosphamide-induced ovarian failure. N Engl J Med. 1973;289(22):1159-1162.
-
(1973)
N Engl J Med
, vol.289
, Issue.22
, pp. 1159-1162
-
-
Warne, G.L.1
Fairley, K.F.2
Hobbs, J.B.3
Martin, F.I.4
-
4
-
-
0029864362
-
Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer
-
Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol. 1996;14(5):1718-1729. (Pubitemid 26134232)
-
(1996)
Journal of Clinical Oncology
, vol.14
, Issue.5
, pp. 1718-1729
-
-
Bines, J.1
Oleske, D.M.2
Cobleigh, M.A.3
-
5
-
-
26444542783
-
Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane
-
Fornier MN, Modi S, Panageas KS, Norton L, Hudis C. Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane. Cancer. 2005;104(8):1575-1579.
-
(2005)
Cancer
, vol.104
, Issue.8
, pp. 1575-1579
-
-
Fornier, M.N.1
Modi, S.2
Panageas, K.S.3
Norton, L.4
Hudis, C.5
-
6
-
-
77953169551
-
Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer
-
Swain SM, Jeong JH, Geyer CE Jr, et al. Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N Engl J Med. 2010;362(22):2053-2065.
-
(2010)
N Engl J Med
, vol.362
, Issue.22
, pp. 2053-2065
-
-
Swain, S.M.1
Jeong, J.H.2
Geyer Jr., C.E.3
-
7
-
-
79955049786
-
A lower antral follicle count is associated with infertility
-
Rosen MP, Johnstone E, Addauan-Andersen C, Cedars MI. A lower antral follicle count is associated with infertility. Fertil Steril. 2011;95(6):1950-1954.
-
(2011)
Fertil Steril
, vol.95
, Issue.6
, pp. 1950-1954
-
-
Rosen, M.P.1
Johnstone, E.2
Addauan-Andersen, C.3
Cedars, M.I.4
-
8
-
-
79960552565
-
The prevalence of self-reported reproductive impairment in young female cancer survivors throughout California
-
abstract
-
Letourneau JM, Ebbel E, Katz P, Oktay K, et al. The prevalence of self-reported reproductive impairment in young female cancer survivors throughout California [abstract]. Fertil Steril. 2010;94(4):510.
-
(2010)
Fertil Steril
, vol.94
, Issue.4
, pp. 510
-
-
Letourneau, J.M.1
Ebbel, E.2
Katz, P.3
Oktay, K.4
-
9
-
-
77953697699
-
Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer
-
Partridge AH, Ruddy KJ, Gelber S, et al. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Fertil Steril. 2010;94(2):638-644.
-
(2010)
Fertil Steril
, vol.94
, Issue.2
, pp. 638-644
-
-
Partridge, A.H.1
Ruddy, K.J.2
Gelber, S.3
-
10
-
-
77955557956
-
Pharmacological interventions for fertility preservation during chemotherapy: A systematic review and meta-analysis
-
Ben-Aharon I, Gafter-Gvili A, Leibovici L, Stemmer SM. Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and meta-analysis. Breast Cancer Res Treat. 2010;122(3):803-811.
-
(2010)
Breast Cancer Res Treat
, vol.122
, Issue.3
, pp. 803-811
-
-
Ben-Aharon, I.1
Gafter-Gvili, A.2
Leibovici, L.3
Stemmer, S.M.4
-
11
-
-
79960545091
-
Effect of the gondadotropin-releasing hormone analogue triptorelin on the occurence of chemotherapy-induced early menopause in premenopausal women with breast cancer: A randomized trial
-
Del Mastro L, Boni L, Michelotto A, et al. Effect of the gondadotropin-releasing hormone analogue triptorelin on the occurence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. JAMA. 2011;306(3):269-276.
-
(2011)
JAMA
, vol.306
, Issue.3
, pp. 269-276
-
-
Del Mastro, L.1
Boni, L.2
Michelotto, A.3
-
12
-
-
61349159177
-
Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: Prospective randomized study
-
Badawy A, Elnashar A, El-Ashry M, Shahat M. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil Steril. 2009;91(3):694-697.
-
(2009)
Fertil Steril
, vol.91
, Issue.3
, pp. 694-697
-
-
Badawy, A.1
Elnashar, A.2
El-Ashry, M.3
Shahat, M.4
-
13
-
-
70349573528
-
Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: Results from a randomized trial
-
Sverrisdottir A, Nystedt M, Johansson H, Fornander T. Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial. Breast Cancer Res Treat. 2009;117(3):561-567.
-
(2009)
Breast Cancer Res Treat
, vol.117
, Issue.3
, pp. 561-567
-
-
Sverrisdottir, A.1
Nystedt, M.2
Johansson, H.3
Fornander, T.4
-
14
-
-
79959195282
-
Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: The GBG 37 ZORO study
-
Gerber B, von Minckwitz G, Stehle H, et al. Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study. J Clin Oncol. 2011;29(17):2334-2341.
-
(2011)
J Clin Oncol
, vol.29
, Issue.17
, pp. 2334-2341
-
-
Gerber, B.1
Von Minckwitz, G.2
Stehle, H.3
-
15
-
-
67650415551
-
Preservation of ovarian function in young women treated with neoadjuvant chemotherapy for breast cancer: A randomized trial using the GnRH agonist (triptorelin) during chemotherapy
-
abstract
-
Ismail-Kahn R, Minton S, Cox C, et al. Preservation of ovarian function in young women treated with neoadjuvant chemotherapy for breast cancer: a randomized trial using the GnRH agonist (triptorelin) during chemotherapy [abstract]. J Clin Oncol. 2008(suppl):26.
-
(2008)
J Clin Oncol
, Issue.SUPPL.
, pp. 26
-
-
Ismail-Kahn, R.1
Minton, S.2
Cox, C.3
-
16
-
-
79952005263
-
The OPTION trial of adjuvant ovarian protection by goserelin in adjuvant chemotherapy for early breast cancer
-
abstract
-
Leonard RC, Adamson D, Anderson R, et al. The OPTION trial of adjuvant ovarian protection by goserelin in adjuvant chemotherapy for early breast cancer [abstract]. J Clin Oncol. 2010;28(suppl):15S.
-
(2010)
J Clin Oncol
, vol.28
, Issue.SUPPL.
-
-
Leonard, R.C.1
Adamson, D.2
Anderson, R.3
|